Results 31 to 40 of about 417,988 (310)
Therapeutic drug monitoring – antiepileptic drugs [PDF]
British Journal of Clinical Pharmacology, 1998 Aims To provide a brief critical review of the basis and contemporary practice of monitoring the concentrations of antiepileptic drugs in biological fluids. Methods The review is based on literature data and observations from clinical practice.
openaire +9 more sources
TGF-β1 and TGFβR2 Gene Polymorphisms in Patients with Unstable Angina
Biomedicines, 2023 Acute coronary syndromes result from a sudden reduction in the lumen of a coronary artery as a result of atherosclerotic plaque rupture, its swelling or the formation of thrombotic lesions.
Damian Malinowski +2 more
doaj +1 more source
YAKUGAKU ZASSHI, 2007 AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Tadaaki, Ito +5 more
openaire +3 more sources
Therapeutic drug monitoring in drug overdose [PDF]
British Journal of Clinical Pharmacology, 1999 The treatment of poisoned patients is still largely defined by history, clinical assessment and interpretation of ancillary investigations. Measurement of drug concentrations is clinically important for relatively few compounds. Most measurements form an adjunct to and should not be considered a substitute for clinical assessment.
A H, Dawson, I M, Whyte
openaire +5 more sources
Frontiers in Immunology, 2023 IntroductionBiologics is used for treating moderate to severe plaque psoriasis (MSPP), which represent one of the foremost therapeutic advancements in disease of dermatology.
Weiqi Gao +10 more
doaj +1 more source
Therapeutic drug monitoring of immunosuppressant drugs [PDF]
British Journal of Clinical Pharmacology, 1999 Individualizing a patient’s drug therapy to obtain the optimum balance between therapeutic efficacy and the occurrence of adverse events is the physician’s goal. However, achieving this goal is not always straight forward, being complicated by within and between patient variability in both pharmacokinetics and pharmacodynamics.
A, Johnston, D W, Holt
openaire +2 more sources
Two cases of a pharmacokinetic interaction between (val)acyclovir and mycophenolate mofetil
Clinical Infection in Practice, 2023 Background: Administration of (val)acyclovir in combination with mycophenolate mofetil (MMF) can result in increased acyclovir plasma levels due to competition with acyclovir for renal tubular secretion.
F.A. Berger +2 more
doaj +1 more source
A Compilation of Serum Concentrations of 12 Antipsychotic Drugs in a Therapeutic Drug Monitoring Setting [PDF]
, 2019 BACKGROUND: No comprehensive collection of routine therapeutic drug monitoring data for antipsychotic drugs has been published. METHODS: In this compilation, data on 12 antipsychotics are presented.
Anna K. Jönsson +8 more
core +1 more source
Therapeutic drug monitoring: antiarrhythmic drugs [PDF]
British Journal of Clinical Pharmacology, 1998 Antiarrhythmic agents are traditionally classified according to Vaughan Williams into four classes of action. Class I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics, and have as a common action, blockade of the fast‐inward sodium channel on myocardium. These agents have a very significant toxicity, and while
T J, Campbell, K M, Williams
openaire +4 more sources
Journal of Intensive Care, 2018 Background Analgosedation is a cornerstone therapy for mechanically ventilated patients in intensive care units (ICU). To avoid inadequate sedation and its complications, monitoring of analgosedation is of great importance.
Richard J. Nies +9 more
doaj +1 more source